| Reference |
|---|
Yu D, Zhao J, Lee E, Kim D, Mahapatra R, Rose E, et al. GLUT3 promotes macrophage signaling and function via RAS-mediated endocytosis in atopic dermatitis and wound healing. J Clin Invest. 2023;133: pubmed publisher |
Chen L, Li Y, Chen Y. KLHL7 promotes hepatocellular carcinoma progression and molecular therapy resistance by degrading RASA2. iScience. 2023;26:106914 pubmed publisher |
Kim J, Jeon Y, Lim S, Ryu J, Lee J, Chang I, et al. Akt-mediated Ephexin1-Ras interaction promotes oncogenic Ras signaling and colorectal and lung cancer cell proliferation. Cell Death Dis. 2021;12:1013 pubmed publisher |
Zhou Z, Ambrogio C, Bera A, Li Q, Li X, Li L, et al. KRASQ61H preferentially signals through MAPK in a RAF dimer-dependent manner in non-small cell lung cancer. Cancer Res. 2020;: pubmed publisher |
Johnson C, Lin Y, Reid D, Parker J, Pavlopoulos S, Dischinger P, et al. Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D. Cell Rep. 2019;28:1538-1550.e7 pubmed publisher |
Luhtala N, Hunter T. Failure to detect functional transfer of active K-Ras protein from extracellular vesicles into recipient cells in culture. PLoS ONE. 2018;13:e0203290 pubmed publisher |
Koraïchi F, Gence R, Bouchenot C, Grosjean S, Lajoie Mazenc I, Favre G, et al. High-content tripartite split-GFP cell-based assays to screen for modulators of small GTPase activation. J Cell Sci. 2018;131: pubmed publisher |
Jinesh G, Kamat A. The Blebbishield Emergency Program Overrides Chromosomal Instability and Phagocytosis Checkpoints in Cancer Stem Cells. Cancer Res. 2017;77:6144-6156 pubmed publisher |
Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, et al. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017;36:4778-4789 pubmed publisher |
Taoka R, Jinesh G, Xue W, Safe S, Kamat A. CF3DODA-Me induces apoptosis, degrades Sp1, and blocks the transformation phase of the blebbishield emergency program. Apoptosis. 2017;22:719-729 pubmed publisher |
Modica T, Maiorani O, Sartori G, Pivetta E, Doliana R, Capuano A, et al. The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4β1 integrin and decreases tumor cell growth. Oncotarget. 2017;8:27034-27046 pubmed publisher |
Luhtala N, Aslanian A, Yates J, Hunter T. Secreted Glioblastoma Nanovesicles Contain Intracellular Signaling Proteins and Active Ras Incorporated in a Farnesylation-dependent Manner. J Biol Chem. 2017;292:611-628 pubmed publisher |
Jinesh G, Molina J, Huang L, Laing N, Mills G, Bar Eli M, et al. Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis. Cell Death Discov. 2016;2:16003 pubmed publisher |
Yang M, Lewinska M, Fan X, Zhu J, Yuan Z. PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis. Oncogene. 2016;35:5527-5538 pubmed publisher |
Leiser D, Medová M, Mikami K, Nisa L, Stroka D, Blaukat A, et al. KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells. Mol Oncol. 2015;9:1434-46 pubmed publisher |
Zhang C, Li R, Jiang H, Lin S, Rogalski J, Liu K, et al. Development and application of a quantitative multiplexed small GTPase activity assay using targeted proteomics. J Proteome Res. 2015;14:967-76 pubmed publisher |
Brtva T, Drugan J, Ghosh S, Terrell R, Campbell Burk S, Bell R, et al. Two distinct Raf domains mediate interaction with Ras. J Biol Chem. 1995;270:9809-12 pubmed |
